PT Hanjaya Mandala Sampoerna Tbk (FRA:HSZ)
Germany · Delayed Price · Currency is EUR 0.0300
+0.0030 (11.11%)
At close: Jul 30, 2025, 10:00 PM CET
Verve Therapeutics Cash Flow Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 5,457,438 | 6,645,774 | 8,096,811 | 6,323,744 | 7,137,097 | 8,581,378 | Upgrade |
Depreciation & Amortization | 1,204,166 | 1,204,166 | 1,131,385 | 1,128,085 | 1,180,156 | 1,349,396 | Upgrade |
Other Operating Activities | -5,658,921 | -2,685,868 | -2,946,052 | -96,493 | 1,985,153 | 2,022,265 | Upgrade |
Operating Cash Flow | 1,002,683 | 5,164,072 | 6,282,144 | 7,355,336 | 10,302,406 | 11,953,039 | Upgrade |
Operating Cash Flow Growth | -89.94% | -17.80% | -14.59% | -28.61% | -13.81% | -30.29% | Upgrade |
Capital Expenditures | -1,046,490 | -1,826,791 | -1,701,907 | -2,178,822 | -412,270 | -566,828 | Upgrade |
Sale of Property, Plant & Equipment | 19,354 | 65,078 | 3,270 | 6,446 | 59,622 | 5,255 | Upgrade |
Divestitures | 4,868 | 4,868 | 579,606 | - | 19,542 | - | Upgrade |
Investment in Securities | -30,593 | - | 7,231 | 22,804 | 688,337 | -308,380 | Upgrade |
Other Investing Activities | 3,054,505 | 4,536,018 | 783,593 | -12,125,000 | -20,783 | 6,225 | Upgrade |
Investing Cash Flow | 2,001,644 | 2,779,173 | -328,207 | -14,274,572 | 334,448 | -863,728 | Upgrade |
Short-Term Debt Issued | - | 18,171 | 30,146 | - | 78,971 | - | Upgrade |
Total Debt Issued | 3,468 | 18,171 | 30,146 | - | 78,971 | - | Upgrade |
Short-Term Debt Repaid | - | - | - | -32,346 | - | -7,265 | Upgrade |
Long-Term Debt Repaid | - | -226,211 | -209,443 | -246,022 | -208,522 | -163,526 | Upgrade |
Total Debt Repaid | -234,407 | -226,211 | -209,443 | -278,368 | -208,522 | -170,791 | Upgrade |
Net Debt Issued (Repaid) | -230,939 | -208,040 | -179,297 | -278,368 | -129,551 | -170,791 | Upgrade |
Common Dividends Paid | -6,534,496 | -8,060,843 | -6,362,599 | -7,362,934 | -8,467,956 | -13,934,906 | Upgrade |
Financing Cash Flow | -6,765,435 | -8,268,883 | -6,541,896 | -7,641,302 | -8,597,507 | -14,105,697 | Upgrade |
Net Cash Flow | -3,761,108 | -325,638 | -587,959 | -14,560,538 | 2,039,347 | -3,016,386 | Upgrade |
Free Cash Flow | -43,807 | 3,337,281 | 4,580,237 | 5,176,514 | 9,890,136 | 11,386,211 | Upgrade |
Free Cash Flow Growth | - | -27.14% | -11.52% | -47.66% | -13.14% | -29.66% | Upgrade |
Free Cash Flow Margin | -0.09% | 6.23% | 8.63% | 11.35% | 23.82% | 28.29% | Upgrade |
Free Cash Flow Per Share | -0.37 | 28.69 | 39.38 | 44.50 | 85.03 | 97.89 | Upgrade |
Cash Interest Paid | 4,222 | 4,222 | 3,199 | 1,578 | 10,558 | 5,400 | Upgrade |
Cash Income Tax Paid | 2,725,296 | 2,725,296 | 2,393,511 | 1,772,076 | 6,315,453 | 2,877,852 | Upgrade |
Levered Free Cash Flow | 1,504,045 | 5,830,384 | 4,517,932 | -8,143,769 | 12,272,572 | 9,299,780 | Upgrade |
Unlevered Free Cash Flow | 1,521,393 | 5,847,571 | 4,533,390 | -8,129,991 | 12,291,466 | 9,318,199 | Upgrade |
Change in Net Working Capital | 3,711,432 | -1,580,636 | 572,335 | 11,996,293 | -6,219,203 | -1,963,983 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.